DIANT® Pharma Inc.
Manchester, US · Founded 2019 · Delaware corporation
Equipment and manufacturing technology company providing continuous processing systems for lipid nanoparticles and other pharmaceutical nanoparticles.
Founders & leadership
DIANT® Pharma Inc. was founded in 2019 by Diane Burgess and Antonio Costa.
DB
Diane BurgessCo-founder
AC
Antonio CostaCo-founder
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2022
▶$1.4MraisedSep 2022 · 4 investors · BiotechnologyRule 506(b)
▶$1.4MraisedSep 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Diane BurgessExecutive Officer, Director
- Antonio CostaExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $1.4M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does DIANT® Pharma Inc. do?
- Equipment and manufacturing technology company providing continuous processing systems for lipid nanoparticles and other pharmaceutical nanoparticles.
- Who founded DIANT® Pharma Inc.?
- DIANT® Pharma Inc. was founded by Diane Burgess, Antonio Costa in 2019.
- How much funding has DIANT® Pharma Inc. raised?
- DIANT® Pharma Inc. has disclosed $1.4M raised across 1 round.
- Where is DIANT® Pharma Inc. headquartered?
- DIANT® Pharma Inc. is headquartered in Manchester, US.